Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for ADHD-Related Insomnia in Children and Adolescents
NCT00252278Phase 4Unknown
- Sponsor
- Rhode Island Hospital
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in attention deficit hyperactivity disorder (ADHD) and Insomnia comparing Atomoxetine with Placebo (2 arms). Primary endpoints: Mean Sleep Onset Latency at 4 weeks and Parent and Child-Reported Evening Settling Difficulties at 4 weeks. Status: unknown.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)Insomnia
Beyond the preview
Go deeper on NCT00252278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252278.